Metropolis Healthcare Ltd. (METROPOLIS) Share Price Hits 52-Week High

Metropolis Healthcare Ltd. Share Price reached a fresh 52-week high of Rs 608.95, marking a 2.24% rise today. The market cap stands at Rs 12,151.82 crore.

Metropolis Healthcare Ltd. Share Price has achieved a significant milestone by reaching a fresh 52-week high of Rs 608.95. The stock opened at Rs 585 and closed at Rs 605, reflecting a 2.24% increase from the previous close of Rs 591.75. The company's market capitalisation is Rs 12,151.82 crore, highlighting its substantial presence in the healthcare sector. This surge in share price underscores the market's positive sentiment towards Metropolis Healthcare Ltd., although the specific catalyst for this rise is not detailed in the available data.

Metropolis Healthcare Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 605
Previous Close	Rs 591.75
Today's Change	+Rs 13.25 (+2.24%)
Day Open	Rs 585
Fresh 52-Week High	Rs 608.95
Day Low	Rs 585
Current Volume	11,213
Turnover	Rs 0.68 crore
Market Capitalisation	Rs 12,151.82 crore

Metropolis Healthcare Ltd. (METROPOLIS) traded at Rs 605. versus the previous close of Rs 591.75, a rise of 2.24%. The stock opened at Rs 585, reached Rs 608.95, touched Rs 585. Reported volume was 11,213.

Today, Metropolis Healthcare Ltd. Share Price opened at Rs 585 and climbed to a high of Rs 608.95, setting a new 52-week peak. The stock closed at Rs 605, up by Rs 13.25 or 2.24% from the previous close of Rs 591.75. The day's trading volume was 11,213 shares, with a turnover of Rs 0.68 crore, indicating moderate market activity. This price movement highlights investor interest, though the data does not specify a particular catalyst for the increase.

Metropolis Healthcare Ltd. (METROPOLIS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,151.82 crore
P/E Ratio	30.28x
P/B Ratio	0.44x
ROE	-2.89%
ROCE	-0.26%

Metropolis Healthcare Ltd. was valued at a P/E ratio of 30.28x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	30.28x
Benchmark Median P/E	21.7x
Benchmark Average P/E	68.16x
Benchmark P/E Range	0x to 3,385.56x
Company P/B Ratio	0.44x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.73%
Company ROCE	-0.26%
Benchmark Median ROCE	13.2%
Company Market Capitalisation	Rs 12,151.82 crore
Benchmark Median Market Cap	Rs 138.42 crore

Metropolis Healthcare Ltd. (METROPOLIS) is classified under sector: Healthcare.

Metropolis Healthcare Ltd. (METROPOLIS) has a P/E ratio of 30.28x, which is above the benchmark median of 21.7x, a difference of +39.54%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Metropolis Healthcare Ltd. (METROPOLIS) has a ROE of -2.89%, which is below the benchmark median of 10.73%, a difference of -126.93%. Metropolis Healthcare Ltd. (METROPOLIS) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,856.59	30.28	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,686.76	40.11	8.17	28.21	26.35
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,432.22	34.7	7.02	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,415.06	171.06	3.16	13.9	12.97
Beta Drugs Ltd.	BETA	2,338.9	59.68	9.44	18.65	22.17

Metropolis Healthcare Ltd. (METROPOLIS) has a P/E ratio of 30.28x compared with the displayed peer median of 40.11x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Metropolis Healthcare Ltd. (METROPOLIS) has a market capitalisation of Rs 12,151.82 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Metropolis Healthcare Ltd.

• Metropolis Healthcare Ltd. Share Price reached a fresh 52-week high of Rs 608.95.
• Valuation metrics suggest potential undervaluation with a P/B ratio of 0.44.
• Negative ROE and ROCE indicate profitability challenges.
• Sector analysis shows a wide range of valuations, with Metropolis positioned attractively.
• Peer comparison highlights valuation appeal but operational hurdles.

About Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd. operates in the healthcare sector, providing diagnostic services across India. The company offers a wide range of tests and healthcare solutions, catering to both individual patients and corporate clients. With a focus on quality and innovation, Metropolis Healthcare Ltd. has established itself as a key player in the diagnostic industry. Despite its strong market presence, the company faces challenges in profitability, as reflected in its negative ROE and ROCE. The company's strategic initiatives and market positioning continue to attract investor attention.

Track Metropolis Healthcare Ltd. Share Price on Univest

Use Metropolis Healthcare Ltd. (METROPOLIS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Metropolis Healthcare Ltd. Share Price, along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. Stay updated with the latest market trends and analysis.

Frequently Asked Questions

What is the current share price of Metropolis Healthcare Ltd.?

Ans. The current share price of Metropolis Healthcare Ltd. is Rs 605, reflecting a 2.24% increase from the previous close of Rs 591.75. The stock moved 2.24% during the session. The intraday range extended from Rs 585 to Rs 608.95.

What was the 52-week high of Metropolis Healthcare Ltd.?

Ans. Metropolis Healthcare Ltd. reached a 52-week high of Rs 608.95 today, indicating strong market interest in the stock. The stock moved 2.24% during the session. The intraday range extended from Rs 585 to Rs 608.95.

How does Metropolis Healthcare Ltd.'s P/E ratio compare to the sector?

Ans. Metropolis Healthcare Ltd.'s P/E ratio of 30.28 is above the sector median of 21.7 but below the sector average of 68.16, suggesting a balanced valuation. The company trades at a P/E ratio of 30.28x.

What are the profitability metrics of Metropolis Healthcare Ltd.?

Ans. Metropolis Healthcare Ltd. reports a negative ROE of -2.89% and a negative ROCE of -0.26%, indicating challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%.

How does Metropolis Healthcare Ltd.'s market cap compare to its peers?

Ans. With a market cap of Rs 12,151.82 crore, Metropolis Healthcare Ltd. is significantly larger than its peers, such as Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd. The company operates in the Healthcare sector.

What is the P/B ratio of Metropolis Healthcare Ltd.?

Ans. Metropolis Healthcare Ltd. has a P/B ratio of 0.44, which is significantly lower than the sector median of 1.9, indicating potential undervaluation. The company trades at a P/E ratio of 30.28x.

Who are the peers of Metropolis Healthcare Ltd.?

Ans. Peers of Metropolis Healthcare Ltd. include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Dr Agarwals Eye Hospital Ltd., among others. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Dr Agarwals Eye Hospital Ltd.